Enalapril Maleate Tablet
Product Images NDC 70518-4153

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Enalapril Maleate (NDC 70518-4153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 01)

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 01)
Chemical structure of Enalapril maleate showing its molecular components including a phenyl group, amino acid derivatives, and maleate moiety.*
FDA Label Image

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02)

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02)
Data table comparing incidence and discontinuation rates of adverse effects between Enalapril maleate (n=673) and placebo (n=339). Categories include Body As A Whole, Cardiovascular, Digestive, Nervous/Psychiatric, Respiratory, Skin, and Urogenital effects, listing various conditions with percentage incidence and discontinuation in parentheses for Enalapril maleate versus incidence for placebo.*
FDA Label Image

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03)

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03)
A table presenting initial recommended dosing of Enalapril maleate tablets based on renal function. It categorizes patients by renal status with corresponding creatinine clearance ranges in mL/min and specifies initial daily doses in mg. The table includes footnotes addressing warnings about anaphylactoid reactions during membrane exposure and dosage adjustments for nondialysis days in dialysis patients.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Enalapril Maleate 20 mg oral tablet bottle label displaying quantity of 90 tablets. The label includes the NDC number 70518-4153-00, manufacturer information as Avet Pharmaceuticals Inc. in East Brunswick, NJ, and repackager RemedyRepack Inc. It indicates storage instructions and a caution to keep medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.